VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 157 filers reported holding VIKING THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,800,699 | -68.1% | 252,999 | -53.3% | 0.00% | -66.7% |
| Q2 2023 | $8,786,955 | +47.6% | 542,070 | +51.6% | 0.00% | +50.0% |
| Q1 2023 | $5,954,789 | +995.7% | 357,645 | +518.6% | 0.00% | – |
| Q4 2022 | $543,461 | +1409.6% | 57,815 | +347.9% | 0.00% | – |
| Q3 2022 | $36,000 | -56.6% | 12,907 | -54.9% | 0.00% | – |
| Q2 2022 | $83,000 | -32.5% | 28,641 | -29.9% | 0.00% | – |
| Q1 2022 | $123,000 | -61.7% | 40,858 | -41.5% | 0.00% | – |
| Q4 2021 | $321,000 | -55.5% | 69,833 | -39.2% | 0.00% | – |
| Q3 2021 | $722,000 | -4.6% | 114,937 | -9.0% | 0.00% | – |
| Q2 2021 | $757,000 | -48.3% | 126,300 | -45.5% | 0.00% | – |
| Q1 2021 | $1,464,000 | +109.7% | 231,541 | +86.9% | 0.00% | – |
| Q4 2020 | $698,000 | -43.9% | 123,858 | -42.1% | 0.00% | -100.0% |
| Q3 2020 | $1,244,000 | -52.0% | 213,791 | -40.5% | 0.00% | -50.0% |
| Q2 2020 | $2,591,000 | +1833.6% | 359,388 | +1154.2% | 0.00% | – |
| Q1 2020 | $134,000 | +44.1% | 28,655 | +146.3% | 0.00% | – |
| Q4 2019 | $93,000 | -43.3% | 11,633 | -51.1% | 0.00% | – |
| Q3 2019 | $164,000 | -16.3% | 23,811 | +1.2% | 0.00% | – |
| Q2 2019 | $196,000 | -90.9% | 23,525 | -89.2% | 0.00% | -100.0% |
| Q1 2019 | $2,158,000 | +1358.1% | 217,087 | +1019.0% | 0.00% | – |
| Q4 2018 | $148,000 | -95.4% | 19,400 | -89.4% | 0.00% | -100.0% |
| Q3 2018 | $3,198,000 | – | 183,565 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |